Motif 324 (n=77)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0C4DFX4 | None | S2610 | ochoa | Snf2 related CREBBP activator protein | None |
O14974 | PPP1R12A | S680 | ochoa|psp | Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) | Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity. {ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19245366, ECO:0000269|PubMed:20354225}. |
O15211 | RGL2 | S750 | ochoa | Ral guanine nucleotide dissociation stimulator-like 2 (RalGDS-like 2) (RalGDS-like factor) (Ras-associated protein RAB2L) | Probable guanine nucleotide exchange factor. Putative effector of Ras and/or Rap. Associates with the GTP-bound form of Rap 1A and H-Ras in vitro (By similarity). {ECO:0000250}. |
O60292 | SIPA1L3 | S1544 | ochoa | Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3) | Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217). {ECO:0000269|PubMed:26231217}. |
O75376 | NCOR1 | S2105 | ochoa | Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) | Mediates transcriptional repression by certain nuclear receptors (PubMed:20812024). Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Mediates the NR1D1-dependent repression and circadian regulation of TSHB expression (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). {ECO:0000250|UniProtKB:Q60974, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:20812024}. |
P15822 | HIVEP1 | S1143 | ochoa | Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV-1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, and interferon-beta genes. It may act in T-cell activation. Involved in activating HIV-1 gene expression. Isoform 2 and isoform 3 also bind to the IPCS (IRF1 and p53 common sequence) DNA sequence in the promoter region of interferon regulatory factor 1 and p53 genes and are involved in transcription regulation of these genes. Isoform 2 does not activate HIV-1 gene expression. Isoform 2 and isoform 3 may be involved in apoptosis. |
P23588 | EIF4B | S430 | ochoa | Eukaryotic translation initiation factor 4B (eIF-4B) | Required for the binding of mRNA to ribosomes. Functions in close association with EIF4-F and EIF4-A. Binds near the 5'-terminal cap of mRNA in presence of EIF-4F and ATP. Promotes the ATPase activity and the ATP-dependent RNA unwinding activity of both EIF4-A and EIF4-F. |
P28290 | ITPRID2 | S752 | ochoa | Protein ITPRID2 (Cleavage signal-1 protein) (CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2) | None |
P38159 | RBMX | Y285 | ochoa | RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed] | RNA-binding protein that plays several role in the regulation of pre- and post-transcriptional processes. Implicated in tissue-specific regulation of gene transcription and alternative splicing of several pre-mRNAs. Binds to and stimulates transcription from the tumor suppressor TXNIP gene promoter; may thus be involved in tumor suppression. When associated with SAFB, binds to and stimulates transcription from the SREBF1 promoter. Associates with nascent mRNAs transcribed by RNA polymerase II. Component of the supraspliceosome complex that regulates pre-mRNA alternative splice site selection. Can either activate or suppress exon inclusion; acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN2. Represses the splicing of MAPT/Tau exon 10. Binds preferentially to single-stranded 5'-CC[A/C]-rich RNA sequence motifs localized in a single-stranded conformation; probably binds RNA as a homodimer. Binds non-specifically to pre-mRNAs. Also plays a role in the cytoplasmic TNFR1 trafficking pathways; promotes both the IL-1-beta-mediated inducible proteolytic cleavage of TNFR1 ectodomains and the release of TNFR1 exosome-like vesicles to the extracellular compartment. {ECO:0000269|PubMed:12165565, ECO:0000269|PubMed:12761049, ECO:0000269|PubMed:16707624, ECO:0000269|PubMed:18445477, ECO:0000269|PubMed:18541147, ECO:0000269|PubMed:19282290, ECO:0000269|PubMed:21327109}. |
P50402 | EMD | Y34 | psp | Emerin | Stabilizes and promotes the formation of a nuclear actin cortical network. Stimulates actin polymerization in vitro by binding and stabilizing the pointed end of growing filaments. Inhibits beta-catenin activity by preventing its accumulation in the nucleus. Acts by influencing the nuclear accumulation of beta-catenin through a CRM1-dependent export pathway. Links centrosomes to the nuclear envelope via a microtubule association. Required for proper localization of non-farnesylated prelamin-A/C. Together with NEMP1, contributes to nuclear envelope stiffness in germ cells (PubMed:32923640). EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. {ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16680152, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649, ECO:0000269|PubMed:32923640}. |
P51114 | FXR1 | S432 | ochoa | RNA-binding protein FXR1 (FMR1 autosomal homolog 1) (hFXR1p) | mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for various processes, such as neurogenesis, muscle development and spermatogenesis (PubMed:17382880, PubMed:20417602, PubMed:30067974, PubMed:34731628, PubMed:35989368, PubMed:36306353). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (PubMed:17382880, PubMed:34731628). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs, leading to assemble mRNAs into cytoplasmic ribonucleoprotein granules that concentrate mRNAs with associated regulatory factors (By similarity). Required to activate translation of stored mRNAs during late spermatogenesis: acts by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules that recruit translation initiation factor EIF4G3 to activate translation of stored mRNAs in late spermatids (By similarity). Promotes translation of MYC transcripts by recruiting the eIF4F complex to the translation start site (PubMed:34731628). Acts as a negative regulator of inflammation in response to IL19 by promoting destabilization of pro-inflammatory transcripts (PubMed:30067974). Also acts as an inhibitor of inflammation by binding to TNF mRNA, decreasing TNF protein production (By similarity). Acts as a negative regulator of AMPA receptor GRIA2/GluA2 synthesis during long-lasting synaptic potentiation of hippocampal neurons by binding to GRIA2/GluA2 mRNA, thereby inhibiting its translation (By similarity). Regulates proliferation of adult neural stem cells by binding to CDKN1A mRNA and promoting its expression (By similarity). Acts as a regulator of sleep and synaptic homeostasis by regulating translation of transcripts in neurons (By similarity). Required for embryonic and postnatal development of muscle tissue by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules (PubMed:30770808). Involved in the nuclear pore complex localization to the nuclear envelope by preventing cytoplasmic aggregation of nucleoporins: acts by preventing ectopic phase separation of nucleoporins in the cytoplasm via a microtubule-dependent mechanism (PubMed:32706158). Plays a role in the stabilization of PKP2 mRNA and therefore protein abundance, via its interaction with PKP3 (PubMed:25225333). May also do the same for PKP2, PKP3 and DSP via its interaction with PKP1 (PubMed:25225333). Forms a cytoplasmic messenger ribonucleoprotein (mRNP) network by packaging long mRNAs, serving as a scaffold that recruits proteins and signaling molecules. This network facilitates signaling reactions by maintaining proximity between kinases and substrates, crucial for processes like actomyosin reorganization (PubMed:39106863). {ECO:0000250|UniProtKB:Q61584, ECO:0000269|PubMed:17382880, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:25225333, ECO:0000269|PubMed:30067974, ECO:0000269|PubMed:30770808, ECO:0000269|PubMed:32706158, ECO:0000269|PubMed:34731628, ECO:0000269|PubMed:35989368, ECO:0000269|PubMed:36306353, ECO:0000269|PubMed:39106863}. |
P51114 | FXR1 | S496 | ochoa | RNA-binding protein FXR1 (FMR1 autosomal homolog 1) (hFXR1p) | mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for various processes, such as neurogenesis, muscle development and spermatogenesis (PubMed:17382880, PubMed:20417602, PubMed:30067974, PubMed:34731628, PubMed:35989368, PubMed:36306353). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (PubMed:17382880, PubMed:34731628). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs, leading to assemble mRNAs into cytoplasmic ribonucleoprotein granules that concentrate mRNAs with associated regulatory factors (By similarity). Required to activate translation of stored mRNAs during late spermatogenesis: acts by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules that recruit translation initiation factor EIF4G3 to activate translation of stored mRNAs in late spermatids (By similarity). Promotes translation of MYC transcripts by recruiting the eIF4F complex to the translation start site (PubMed:34731628). Acts as a negative regulator of inflammation in response to IL19 by promoting destabilization of pro-inflammatory transcripts (PubMed:30067974). Also acts as an inhibitor of inflammation by binding to TNF mRNA, decreasing TNF protein production (By similarity). Acts as a negative regulator of AMPA receptor GRIA2/GluA2 synthesis during long-lasting synaptic potentiation of hippocampal neurons by binding to GRIA2/GluA2 mRNA, thereby inhibiting its translation (By similarity). Regulates proliferation of adult neural stem cells by binding to CDKN1A mRNA and promoting its expression (By similarity). Acts as a regulator of sleep and synaptic homeostasis by regulating translation of transcripts in neurons (By similarity). Required for embryonic and postnatal development of muscle tissue by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules (PubMed:30770808). Involved in the nuclear pore complex localization to the nuclear envelope by preventing cytoplasmic aggregation of nucleoporins: acts by preventing ectopic phase separation of nucleoporins in the cytoplasm via a microtubule-dependent mechanism (PubMed:32706158). Plays a role in the stabilization of PKP2 mRNA and therefore protein abundance, via its interaction with PKP3 (PubMed:25225333). May also do the same for PKP2, PKP3 and DSP via its interaction with PKP1 (PubMed:25225333). Forms a cytoplasmic messenger ribonucleoprotein (mRNP) network by packaging long mRNAs, serving as a scaffold that recruits proteins and signaling molecules. This network facilitates signaling reactions by maintaining proximity between kinases and substrates, crucial for processes like actomyosin reorganization (PubMed:39106863). {ECO:0000250|UniProtKB:Q61584, ECO:0000269|PubMed:17382880, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:25225333, ECO:0000269|PubMed:30067974, ECO:0000269|PubMed:30770808, ECO:0000269|PubMed:32706158, ECO:0000269|PubMed:34731628, ECO:0000269|PubMed:35989368, ECO:0000269|PubMed:36306353, ECO:0000269|PubMed:39106863}. |
P51116 | FXR2 | T610 | ochoa | RNA-binding protein FXR2 (FXR2P) (FMR1 autosomal homolog 2) | mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for adult hippocampal neurogenesis (By similarity). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs: mRNAs storage into membraneless compartments regulates their translation and/or stability (By similarity). Acts as a regulator of adult hippocampal neurogenesis by regulating translation and/or stability of NOG mRNA, thereby preventing NOG protein expression in the dentate gyrus (By similarity). {ECO:0000250|UniProtKB:Q61584, ECO:0000250|UniProtKB:Q9WVR4}. |
P51116 | FXR2 | S622 | ochoa | RNA-binding protein FXR2 (FXR2P) (FMR1 autosomal homolog 2) | mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for adult hippocampal neurogenesis (By similarity). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs: mRNAs storage into membraneless compartments regulates their translation and/or stability (By similarity). Acts as a regulator of adult hippocampal neurogenesis by regulating translation and/or stability of NOG mRNA, thereby preventing NOG protein expression in the dentate gyrus (By similarity). {ECO:0000250|UniProtKB:Q61584, ECO:0000250|UniProtKB:Q9WVR4}. |
P52799 | EFNB2 | S270 | ochoa | Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L) | Cell surface transmembrane ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds to receptor tyrosine kinase including EPHA4, EPHA3 and EPHB4. Together with EPHB4 plays a central role in heart morphogenesis and angiogenesis through regulation of cell adhesion and cell migration. EPHB4-mediated forward signaling controls cellular repulsion and segregation from EFNB2-expressing cells. May play a role in constraining the orientation of longitudinally projecting axons. {ECO:0000269|PubMed:12734395}.; FUNCTION: (Microbial infection) Acts as a receptor for Hendra virus and Nipah virus. {ECO:0000269|PubMed:15998730, ECO:0000269|PubMed:16007075, ECO:0000269|PubMed:16477309, ECO:0000269|PubMed:17376907}. |
P52926 | HMGA2 | S44 | ochoa | High mobility group protein HMGI-C (High mobility group AT-hook protein 2) | Functions as a transcriptional regulator. Functions in cell cycle regulation through CCNA2. Plays an important role in chromosome condensation during the meiotic G2/M transition of spermatocytes. Plays a role in postnatal myogenesis, is involved in satellite cell activation (By similarity). Positively regulates IGF2 expression through PLAG1 and in a PLAG1-independent manner (PubMed:28796236). {ECO:0000250|UniProtKB:P52927, ECO:0000269|PubMed:14645522, ECO:0000269|PubMed:28796236}. |
Q07955 | SRSF1 | S223 | psp | Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit) | Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors. May function as export adapter involved in mRNA nuclear export through the TAP/NXF1 pathway. {ECO:0000269|PubMed:8139654}. |
Q10570 | CPSF1 | S765 | ochoa | Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) | Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. This subunit is involved in the RNA recognition step of the polyadenylation reaction (PubMed:14749727). May play a role in eye morphogenesis and the development of retinal ganglion cell projections to the midbrain (By similarity). {ECO:0000250|UniProtKB:A0A0R4IC37, ECO:0000269|PubMed:14749727}. |
Q13242 | SRSF9 | S189 | ochoa | Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9) | Plays a role in constitutive splicing and can modulate the selection of alternative splice sites. Represses the splicing of MAPT/Tau exon 10. {ECO:0000269|PubMed:10196175, ECO:0000269|PubMed:11875052, ECO:0000269|PubMed:12024014, ECO:0000269|PubMed:12604611, ECO:0000269|PubMed:15009090, ECO:0000269|PubMed:15009664, ECO:0000269|PubMed:15695522, ECO:0000269|PubMed:7556075}. |
Q13243 | SRSF5 | S86 | psp | Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5) | Plays a role in constitutive splicing and can modulate the selection of alternative splice sites. |
Q13563 | PKD2 | S76 | ochoa|psp | Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2) | Forms a nonselective cation channel (PubMed:11854751, PubMed:11991947, PubMed:15692563, PubMed:26269590, PubMed:27071085, PubMed:31441214, PubMed:39009345). Can function as a homotetrameric ion channel or can form heteromer with PKD1 (PubMed:31441214, PubMed:33164752). Displays distinct function depending on its subcellular localization and regulation by its binding partners (PubMed:11854751, PubMed:11991947, PubMed:27214281, PubMed:29899465). In primary cilium functions as a cation channel, with a preference for monovalent cations over divalent cations that allows K(+), Na(+) and Ca(2+) influx, with low selectivity for Ca(2+) (PubMed:27071085). Involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (By similarity). In the endoplasmic reticulum, likely functions as a K(+) channel to facilitate Ca(2+) release (By similarity). The heterotetrameric PKD1/PKD2 channel has higher Ca(2+) permeability than homomeric PKD2 channel and acts as a primarily Ca(2+)-permeable channel (PubMed:31441214). Interacts with and acts as a regulator of a number of other channels, such as TRPV4, TRPC1, IP3R, RYR2, ultimately further affecting intracellular signaling, to modulate intracellular Ca(2+) signaling (PubMed:11854751, PubMed:11991947, PubMed:27214281, PubMed:29899465). Together with TRPV4, forms mechano- and thermosensitive channels in cilium (PubMed:18695040). In cardiomyocytes, PKD2 modulates Ca(2+) release from stimulated RYR2 receptors through direct association (By similarity). Also involved in left-right axis specification via its role in sensing nodal flow; forms a complex with PKD1L1 in cilia to facilitate flow detection in left-right patterning (By similarity). Acts as a regulator of cilium length together with PKD1 (By similarity). Mediates systemic blood pressure and contributes to the myogenic response in cerebral arteries though vasoconstriction (By similarity). {ECO:0000250|UniProtKB:O35245, ECO:0000269|PubMed:11854751, ECO:0000269|PubMed:11991947, ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:26269590, ECO:0000269|PubMed:27071085, ECO:0000269|PubMed:27214281, ECO:0000269|PubMed:29899465, ECO:0000269|PubMed:31441214, ECO:0000269|PubMed:33164752, ECO:0000269|PubMed:39009345}. |
Q14004 | CDK13 | S385 | ochoa | Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
Q14004 | CDK13 | S397 | ochoa | Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
Q16555 | DPYSL2 | S507 | ochoa | Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2) | Plays a role in neuronal development and polarity, as well as in axon growth and guidance, neuronal growth cone collapse and cell migration. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. May play a role in endocytosis. {ECO:0000269|PubMed:11477421, ECO:0000269|PubMed:15466863, ECO:0000269|PubMed:20801876}. |
Q3KQU3 | MAP7D1 | S368 | ochoa | MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1) | Microtubule-stabilizing protein involved in the control of cell motility and neurite outgrowth. Facilitate microtubule stabilization through the maintenance of acetylated stable microtubules. {ECO:0000250|UniProtKB:A2AJI0}. |
Q5T200 | ZC3H13 | S1264 | ochoa | Zinc finger CCCH domain-containing protein 13 | Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (PubMed:29507755). Acts as a key regulator of m6A methylation by promoting m6A methylation of mRNAs at the 3'-UTR (By similarity). Controls embryonic stem cells (ESCs) pluripotency via its role in m6A methylation (By similarity). In the WMM complex, anchors component of the MACOM subcomplex in the nucleus (By similarity). Also required for bridging WTAP to the RNA-binding component RBM15 (RBM15 or RBM15B) (By similarity). {ECO:0000250|UniProtKB:E9Q784}. |
Q68DK2 | ZFYVE26 | S1777 | ochoa | Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin) | Phosphatidylinositol 3-phosphate-binding protein required for the abscission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abscission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}. |
Q6ICG6 | KIAA0930 | S276 | ochoa | Uncharacterized protein KIAA0930 | None |
Q6ICG6 | KIAA0930 | S289 | ochoa | Uncharacterized protein KIAA0930 | None |
Q6NYC8 | PPP1R18 | S209 | ochoa | Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18) | [Isoform 1]: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:24434620}.; FUNCTION: [Isoform 4]: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:17374523}. |
Q6PD62 | CTR9 | S1087 | ochoa | RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1) | Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1; it promotes leukemogenesis through association with KMT2A/MLL1-rearranged oncoproteins, such as KMT2A/MLL1-MLLT3/AF9 and KMT2A/MLL1-MLLT1/ENL. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. In case of infection by influenza A strain H3N2, PAF1C associates with viral NS1 protein, thereby regulating gene transcription. Required for mono- and trimethylation on histone H3 'Lys-4' (H3K4me3) and dimethylation on histone H3 'Lys-79' (H3K4me3). Required for Hox gene transcription. Required for the trimethylation of histone H3 'Lys-4' (H3K4me3) on genes involved in stem cell pluripotency; this function is synergistic with CXXC1 indicative for an involvement of the SET1 complex. Involved in transcriptional regulation of IL6-responsive genes and in JAK-STAT pathway; may regulate DNA-association of STAT3 (By similarity). {ECO:0000250|UniProtKB:Q62018, ECO:0000269|PubMed:16024656, ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19345177, ECO:0000269|PubMed:19952111, ECO:0000269|PubMed:20178742, ECO:0000269|PubMed:20541477, ECO:0000269|PubMed:21329879}. |
Q6WCQ1 | MPRIP | S362 | ochoa | Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip) | Targets myosin phosphatase to the actin cytoskeleton. Required for the regulation of the actin cytoskeleton by RhoA and ROCK1. Depletion leads to an increased number of stress fibers in smooth muscle cells through stabilization of actin fibers by phosphorylated myosin. Overexpression of MRIP as well as its F-actin-binding region leads to disassembly of stress fibers in neuronal cells. {ECO:0000250|UniProtKB:P97434, ECO:0000269|PubMed:15545284, ECO:0000269|PubMed:16257966}. |
Q6ZRS2 | SRCAP | S2787 | ochoa | Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator) | Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}. |
Q86WB0 | ZC3HC1 | S344 | ochoa|psp | Zinc finger C3HC-type protein 1 (Nuclear-interacting partner of ALK) (hNIPA) (Nuclear-interacting partner of anaplastic lymphoma kinase) | Required for proper positioning of a substantial amount of TPR at the nuclear basket (NB) through interaction with TPR. {ECO:0000269|PubMed:34440706}. |
Q8IYB3 | SRRM1 | S551 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8N699 | MYCT1 | S114 | ochoa | Myc target protein 1 (Myc target in myeloid cells protein 1) | May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity). {ECO:0000250}. |
Q8TF72 | SHROOM3 | S1021 | ochoa | Protein Shroom3 (Shroom-related protein) (hShrmL) | Controls cell shape changes in the neuroepithelium during neural tube closure. Induces apical constriction in epithelial cells by promoting the apical accumulation of F-actin and myosin II, and probably by bundling stress fibers (By similarity). Induces apicobasal cell elongation by redistributing gamma-tubulin and directing the assembly of robust apicobasal microtubule arrays (By similarity). {ECO:0000250|UniProtKB:Q27IV2, ECO:0000250|UniProtKB:Q9QXN0}. |
Q8TF76 | HASPIN | T97 | ochoa|psp | Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) | Serine/threonine-protein kinase that phosphorylates histone H3 at 'Thr-3' (H3T3ph) during mitosis. May act through H3T3ph to both position and modulate activation of AURKB and other components of the chromosomal passenger complex (CPC) at centromeres to ensure proper chromatid cohesion, metaphase alignment and normal progression through the cell cycle. {ECO:0000269|PubMed:11228240, ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:17084365, ECO:0000269|PubMed:20705812, ECO:0000269|PubMed:20929775}. |
Q8WX93 | PALLD | S1106 | ochoa | Palladin (SIH002) (Sarcoma antigen NY-SAR-77) | Cytoskeletal protein required for organization of normal actin cytoskeleton. Roles in establishing cell morphology, motility, cell adhesion and cell-extracellular matrix interactions in a variety of cell types. May function as a scaffolding molecule with the potential to influence both actin polymerization and the assembly of existing actin filaments into higher-order arrays. Binds to proteins that bind to either monomeric or filamentous actin. Localizes at sites where active actin remodeling takes place, such as lamellipodia and membrane ruffles. Different isoforms may have functional differences. Involved in the control of morphological and cytoskeletal changes associated with dendritic cell maturation. Involved in targeting ACTN to specific subcellular foci. {ECO:0000269|PubMed:11598191, ECO:0000269|PubMed:15147863, ECO:0000269|PubMed:17537434}. |
Q96E39 | RBMXL1 | Y285 | ochoa | RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1) | RNA-binding protein which may be involved in pre-mRNA splicing. {ECO:0000250}. |
Q96JY6 | PDLIM2 | Y122 | ochoa | PDZ and LIM domain protein 2 (PDZ-LIM protein mystique) | Probable adapter protein located at the actin cytoskeleton that promotes cell attachment. Necessary for the migratory capacity of epithelial cells. Overexpression enhances cell adhesion to collagen and fibronectin and suppresses anchorage independent growth. May contribute to tumor cell migratory capacity. {ECO:0000269|PubMed:15659642}. |
Q96T58 | SPEN | S635 | ochoa | Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250|UniProtKB:Q62504, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}. |
Q96T58 | SPEN | S725 | ochoa | Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250|UniProtKB:Q62504, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}. |
Q99501 | GAS2L1 | S306 | ochoa | GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1) | Involved in the cross-linking of microtubules and microfilaments (PubMed:12584248, PubMed:24706950). Regulates microtubule dynamics and stability by interacting with microtubule plus-end tracking proteins, such as MAPRE1, to regulate microtubule growth along actin stress fibers (PubMed:24706950). {ECO:0000269|PubMed:12584248, ECO:0000269|PubMed:24706950}. |
Q9BRD0 | BUD13 | S185 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S211 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9H8V3 | ECT2 | S397 | ochoa|psp | Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) | Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP. Promotes guanine nucleotide exchange on the Rho family members of small GTPases, like RHOA, RHOC, RAC1 and CDC42. Required for signal transduction pathways involved in the regulation of cytokinesis. Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Regulates the translocation of RHOA from the central spindle to the equatorial region. Plays a role in the control of mitotic spindle assembly; regulates the activation of CDC42 in metaphase for the process of spindle fibers attachment to kinetochores before chromosome congression. Involved in the regulation of epithelial cell polarity; participates in the formation of epithelial tight junctions in a polarity complex PARD3-PARD6-protein kinase PRKCQ-dependent manner. Plays a role in the regulation of neurite outgrowth. Inhibits phenobarbital (PB)-induced NR1I3 nuclear translocation. Stimulates the activity of RAC1 through its association with the oncogenic PARD6A-PRKCI complex in cancer cells, thereby acting to coordinately drive tumor cell proliferation and invasion. Also stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death. {ECO:0000269|PubMed:10579713, ECO:0000269|PubMed:14645260, ECO:0000269|PubMed:15254234, ECO:0000269|PubMed:15545273, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16170345, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16495035, ECO:0000269|PubMed:19129481, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19617897, ECO:0000269|PubMed:21189248, ECO:0000269|PubMed:21373644, ECO:0000269|PubMed:25068414, ECO:0000269|PubMed:31888991}. |
Q9HCG8 | CWC22 | S49 | ochoa | Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb) | Required for pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:12226669, PubMed:22961380, PubMed:28076346, PubMed:28502770, PubMed:29301961, PubMed:29360106). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Promotes exon-junction complex (EJC) assembly (PubMed:22959432, PubMed:22961380). Hinders EIF4A3 from non-specifically binding RNA and escorts it to the splicing machinery to promote EJC assembly on mature mRNAs. Through its role in EJC assembly, required for nonsense-mediated mRNA decay. {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12226669, ECO:0000269|PubMed:22959432, ECO:0000269|PubMed:22961380, ECO:0000269|PubMed:23236153, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000305|PubMed:33509932}. |
Q9HCP0 | CSNK1G1 | S344 | psp | Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) | Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Regulates fast synaptic transmission mediated by glutamate (By similarity). Phosphorylates CLSPN. {ECO:0000250, ECO:0000269|PubMed:21680713}. |
Q9HD20 | ATP13A1 | S905 | ochoa | Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase) | Endoplasmic reticulum translocase required to remove mitochondrial transmembrane proteins mistargeted to the endoplasmic reticulum (PubMed:32973005, PubMed:36264797). Acts as a dislocase that mediates the ATP-dependent extraction of mislocalized mitochondrial transmembrane proteins from the endoplasmic reticulum membrane (PubMed:32973005). Specifically binds mitochondrial tail-anchored transmembrane proteins: has an atypically large substrate-binding pocket that recognizes and binds moderately hydrophobic transmembranes with short hydrophilic lumenal domains (PubMed:32973005). {ECO:0000269|PubMed:32973005, ECO:0000269|PubMed:36264797}. |
Q9NRL2 | BAZ1A | S1402 | ochoa | Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1) | Regulatory subunit of the ATP-dependent ACF-1 and ACF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and slide edge- and center-positioned histone octamers away from their original location on the DNA template to facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:17099699, PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template in an ATP-dependent manner (PubMed:14759371, PubMed:17099699, PubMed:28801535). The ACF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the ACF-5 ISWI chromatin remodeling complex (PubMed:28801535). Has a role in sensing the length of DNA which flank nucleosomes, which modulates the nucleosome spacing activity of the ACF-5 ISWI chromatin remodeling complex (PubMed:17099699). Involved in DNA replication and together with SMARCA5/SNF2H is required for replication of pericentric heterochromatin in S-phase (PubMed:12434153). May have a role in nuclear receptor-mediated transcription repression (PubMed:17519354). {ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:14759371, ECO:0000269|PubMed:17099699, ECO:0000269|PubMed:17519354, ECO:0000269|PubMed:28801535}. |
Q9NVW2 | RLIM | S215 | psp | E3 ubiquitin-protein ligase RLIM (EC 2.3.2.27) (LIM domain-interacting RING finger protein) (RING finger LIM domain-binding protein) (R-LIM) (RING finger protein 12) (RING-type E3 ubiquitin transferase RLIM) (Renal carcinoma antigen NY-REN-43) | E3 ubiquitin-protein ligase. Acts as a negative coregulator for LIM homeodomain transcription factors by mediating the ubiquitination and subsequent degradation of LIM cofactors LDB1 and LDB2 and by mediating the recruitment the SIN3a/histone deacetylase corepressor complex. Ubiquitination and degradation of LIM cofactors LDB1 and LDB2 allows DNA-bound LIM homeodomain transcription factors to interact with other protein partners such as RLIM. Plays a role in telomere length-mediated growth suppression by mediating the ubiquitination and degradation of TERF1. By targeting ZFP42 for degradation, acts as an activator of random inactivation of X chromosome in the embryo, a stochastic process in which one X chromosome is inactivated to minimize sex-related dosage differences of X-encoded genes in somatic cells of female placental mammals. {ECO:0000269|PubMed:19164295, ECO:0000269|PubMed:19945382}. |
Q9NWH9 | SLTM | S999 | ochoa | SAFB-like transcription modulator (Modulator of estrogen-induced transcription) | When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. {ECO:0000250}. |
Q9NXH8 | TOR4A | S87 | ochoa | Torsin-4A (Torsin family 4 member A) | None |
Q9NYV4 | CDK12 | S288 | ochoa | Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) | Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors. {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820, ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:24662513}. |
Q9NZM5 | NOP53 | S29 | ochoa | Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1) (PICT-1) (p60) | Nucleolar protein which is involved in the integration of the 5S RNP into the ribosomal large subunit during ribosome biogenesis (PubMed:24120868). In ribosome biogenesis, may also play a role in rRNA transcription (PubMed:27729611). Also functions as a nucleolar sensor that regulates the activation of p53/TP53 in response to ribosome biogenesis perturbation, DNA damage and other stress conditions (PubMed:21741933, PubMed:24120868, PubMed:27829214). DNA damage or perturbation of ribosome biogenesis disrupt the interaction between NOP53 and RPL11 allowing RPL11 transport to the nucleoplasm where it can inhibit MDM2 and allow p53/TP53 activation (PubMed:24120868, PubMed:27829214). It may also positively regulate the function of p53/TP53 in cell cycle arrest and apoptosis through direct interaction, preventing its MDM2-dependent ubiquitin-mediated proteasomal degradation (PubMed:22522597). Originally identified as a tumor suppressor, it may also play a role in cell proliferation and apoptosis by positively regulating the stability of PTEN, thereby antagonizing the PI3K-AKT/PKB signaling pathway (PubMed:15355975, PubMed:16971513, PubMed:27729611). May also inhibit cell proliferation and increase apoptosis through its interaction with NF2 (PubMed:21167305). May negatively regulate NPM1 by regulating its nucleoplasmic localization, oligomerization and ubiquitin-mediated proteasomal degradation (PubMed:25818168). Thereby, may prevent NPM1 interaction with MYC and negatively regulate transcription mediated by the MYC-NPM1 complex (PubMed:25956029). May also regulate cellular aerobic respiration (PubMed:24556985). In the cellular response to viral infection, may play a role in the attenuation of interferon-beta through the inhibition of RIGI (PubMed:27824081). {ECO:0000269|PubMed:15355975, ECO:0000269|PubMed:16971513, ECO:0000269|PubMed:21167305, ECO:0000269|PubMed:21741933, ECO:0000269|PubMed:22522597, ECO:0000269|PubMed:24120868, ECO:0000269|PubMed:24556985, ECO:0000269|PubMed:25818168, ECO:0000269|PubMed:25956029, ECO:0000269|PubMed:27729611, ECO:0000269|PubMed:27824081, ECO:0000269|PubMed:27829214}. |
Q9P206 | NHSL3 | S327 | ochoa | NHS-like protein 3 | Able to directly activate the TNF-NFkappaB signaling pathway. {ECO:0000269|PubMed:32854746}. |
Q9UNF1 | MAGED2 | S244 | ochoa | Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen) | Regulates the expression, localization to the plasma membrane and function of the sodium chloride cotransporters SLC12A1 and SLC12A3, two key components of salt reabsorption in the distal renal tubule. {ECO:0000269|PubMed:27120771}. |
Q9UPN3 | MACF1 | S7236 | ochoa | Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha) | [Isoform 2]: F-actin-binding protein which plays a role in cross-linking actin to other cytoskeletal proteins and also binds to microtubules (PubMed:15265687, PubMed:20937854). Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex (PubMed:20937854). Acts as a positive regulator of Wnt receptor signaling pathway and is involved in the translocation of AXIN1 and its associated complex (composed of APC, CTNNB1 and GSK3B) from the cytoplasm to the cell membrane (By similarity). Has actin-regulated ATPase activity and is essential for controlling focal adhesions (FAs) assembly and dynamics (By similarity). Interaction with CAMSAP3 at the minus ends of non-centrosomal microtubules tethers microtubules minus-ends to actin filaments, regulating focal adhesion size and cell migration (PubMed:27693509). May play role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with GOLGA4 (PubMed:15265687). Plays a key role in wound healing and epidermal cell migration (By similarity). Required for efficient upward migration of bulge cells in response to wounding and this function is primarily rooted in its ability to coordinate microtubule dynamics and polarize hair follicle stem cells (By similarity). As a regulator of actin and microtubule arrangement and stabilization, it plays an essential role in neurite outgrowth, branching and spine formation during brain development (By similarity). {ECO:0000250|UniProtKB:Q9QXZ0, ECO:0000269|PubMed:15265687, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:27693509}. |
Q9UQ35 | SRRM2 | S1830 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1854 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1866 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1878 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1890 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1925 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1972 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1984 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2020 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2032 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2044 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2090 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9Y2H5 | PLEKHA6 | S338 | ochoa | Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3) | None |
Q9Y2H5 | PLEKHA6 | S461 | ochoa | Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3) | None |
Q9Y4D8 | HECTD4 | S1139 | ochoa | Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4) | E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. {ECO:0000250}. |
Q9Y570 | PPME1 | S27 | ochoa | Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) | Demethylates proteins that have been reversibly carboxymethylated. Demethylates PPP2CB (in vitro) and PPP2CA. Binding to PPP2CA displaces the manganese ion and inactivates the enzyme. {ECO:0000269|PubMed:10318862}. |
Q32M45 | ANO4 | S849 | Sugiyama | Anoctamin-4 (Transmembrane protein 16D) | Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylserine, phosphatidylcholine and galactosylceramide (By similarity). Does not exhibit calcium-activated chloride channel (CaCC) activity (By similarity). {ECO:0000250|UniProtKB:Q8C5H1}. |
Q9Y4K4 | MAP4K5 | S423 | Sugiyama | Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) | May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. {ECO:0000269|PubMed:9038372}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-72172 | mRNA Splicing | 0.000002 | 5.782 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.000001 | 5.943 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.000001 | 5.846 |
R-HSA-72187 | mRNA 3'-end processing | 0.000003 | 5.517 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.000006 | 5.224 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.000021 | 4.673 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.000234 | 3.631 |
R-HSA-8953854 | Metabolism of RNA | 0.001028 | 2.988 |
R-HSA-114608 | Platelet degranulation | 0.015445 | 1.811 |
R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex | 0.028893 | 1.539 |
R-HSA-9820865 | Z-decay: degradation of maternal mRNAs by zygotically expressed factors | 0.056965 | 1.244 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 0.074103 | 1.130 |
R-HSA-3928664 | Ephrin signaling | 0.080872 | 1.092 |
R-HSA-429947 | Deadenylation of mRNA | 0.104184 | 0.982 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 0.029646 | 1.528 |
R-HSA-390522 | Striated Muscle Contraction | 0.136481 | 0.865 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.179781 | 0.745 |
R-HSA-72649 | Translation initiation complex formation | 0.203558 | 0.691 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 0.209396 | 0.679 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 0.087593 | 1.058 |
R-HSA-3928662 | EPHB-mediated forward signaling | 0.173728 | 0.760 |
R-HSA-9609523 | Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 0.087593 | 1.058 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.155306 | 0.809 |
R-HSA-399956 | CRMPs in Sema3A signaling | 0.063857 | 1.195 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 0.182791 | 0.738 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.060417 | 1.219 |
R-HSA-350054 | Notch-HLH transcription pathway | 0.097583 | 1.011 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.104184 | 0.982 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 0.197678 | 0.704 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 0.200623 | 0.698 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 0.215191 | 0.667 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.123702 | 0.908 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.218073 | 0.661 |
R-HSA-9707616 | Heme signaling | 0.226657 | 0.645 |
R-HSA-9623433 | NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | 0.053500 | 1.272 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.155306 | 0.809 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.251857 | 0.599 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.039926 | 1.399 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.161491 | 0.792 |
R-HSA-9005895 | Pervasive developmental disorders | 0.056965 | 1.244 |
R-HSA-9697154 | Disorders of Nervous System Development | 0.056965 | 1.244 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 0.056965 | 1.244 |
R-HSA-9733458 | Induction of Cell-Cell Fusion | 0.070700 | 1.151 |
R-HSA-3214815 | HDACs deacetylate histones | 0.206482 | 0.685 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.158404 | 0.800 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.074103 | 1.130 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.080872 | 1.092 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.212299 | 0.673 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.094265 | 1.026 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.017527 | 1.756 |
R-HSA-193648 | NRAGE signals death through JNK | 0.209396 | 0.679 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.226657 | 0.645 |
R-HSA-166208 | mTORC1-mediated signalling | 0.097583 | 1.011 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 0.197678 | 0.704 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 0.130114 | 0.886 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.158404 | 0.800 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.045943 | 1.338 |
R-HSA-373755 | Semaphorin interactions | 0.229498 | 0.639 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 0.133303 | 0.875 |
R-HSA-437239 | Recycling pathway of L1 | 0.182791 | 0.738 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.185790 | 0.731 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.209396 | 0.679 |
R-HSA-936837 | Ion transport by P-type ATPases | 0.232328 | 0.634 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.257347 | 0.589 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.188778 | 0.724 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 0.220945 | 0.656 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.226657 | 0.645 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 0.215191 | 0.667 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.220945 | 0.656 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.220945 | 0.656 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.220945 | 0.656 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.220945 | 0.656 |
R-HSA-983712 | Ion channel transport | 0.177093 | 0.752 |
R-HSA-165159 | MTOR signalling | 0.167632 | 0.776 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.226657 | 0.645 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.133303 | 0.875 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.220945 | 0.656 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.172173 | 0.764 |
R-HSA-69275 | G2/M Transition | 0.173176 | 0.762 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.175786 | 0.755 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.093339 | 1.030 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.133266 | 0.875 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.260076 | 0.585 |
R-HSA-1236394 | Signaling by ERBB4 | 0.260076 | 0.585 |
R-HSA-8852135 | Protein ubiquitination | 0.262796 | 0.580 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.265507 | 0.576 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 0.268207 | 0.572 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.270898 | 0.567 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.270898 | 0.567 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.276250 | 0.559 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.278911 | 0.555 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.284205 | 0.546 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.286838 | 0.542 |
R-HSA-74160 | Gene expression (Transcription) | 0.302854 | 0.519 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.307560 | 0.512 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.312647 | 0.505 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.312647 | 0.505 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.325205 | 0.488 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.327690 | 0.485 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.332632 | 0.478 |
R-HSA-1483255 | PI Metabolism | 0.339978 | 0.469 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.347244 | 0.459 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.347244 | 0.459 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.354432 | 0.450 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.354432 | 0.450 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.354768 | 0.450 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.356811 | 0.448 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.356811 | 0.448 |
R-HSA-2672351 | Stimuli-sensing channels | 0.356811 | 0.448 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.364775 | 0.438 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.380128 | 0.420 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.380128 | 0.420 |
R-HSA-373760 | L1CAM interactions | 0.380128 | 0.420 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.382413 | 0.417 |
R-HSA-68875 | Mitotic Prophase | 0.389220 | 0.410 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.395953 | 0.402 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.402613 | 0.395 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.402613 | 0.395 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.402613 | 0.395 |
R-HSA-9843745 | Adipogenesis | 0.417874 | 0.379 |
R-HSA-9909396 | Circadian clock | 0.420023 | 0.377 |
R-HSA-9609507 | Protein localization | 0.467344 | 0.330 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.469313 | 0.329 |
R-HSA-73887 | Death Receptor Signaling | 0.469313 | 0.329 |
R-HSA-1989781 | PPARA activates gene expression | 0.471275 | 0.327 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.475177 | 0.323 |
R-HSA-9006936 | Signaling by TGFB family members | 0.480977 | 0.318 |
R-HSA-72306 | tRNA processing | 0.501711 | 0.300 |
R-HSA-1640170 | Cell Cycle | 0.503080 | 0.298 |
R-HSA-2559583 | Cellular Senescence | 0.519852 | 0.284 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.534975 | 0.272 |
R-HSA-5617833 | Cilium Assembly | 0.537344 | 0.270 |
R-HSA-9609690 | HCMV Early Events | 0.547536 | 0.262 |
R-HSA-428157 | Sphingolipid metabolism | 0.555861 | 0.255 |
R-HSA-109582 | Hemostasis | 0.570943 | 0.243 |
R-HSA-397014 | Muscle contraction | 0.575231 | 0.240 |
R-HSA-68882 | Mitotic Anaphase | 0.581502 | 0.235 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.583055 | 0.234 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.608610 | 0.216 |
R-HSA-157118 | Signaling by NOTCH | 0.617257 | 0.210 |
R-HSA-422475 | Axon guidance | 0.618602 | 0.209 |
R-HSA-4839726 | Chromatin organization | 0.629876 | 0.201 |
R-HSA-9609646 | HCMV Infection | 0.631253 | 0.200 |
R-HSA-9675108 | Nervous system development | 0.653293 | 0.185 |
R-HSA-9711123 | Cellular response to chemical stress | 0.655188 | 0.184 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.672743 | 0.172 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.681188 | 0.167 |
R-HSA-1483257 | Phospholipid metabolism | 0.688255 | 0.162 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.689418 | 0.162 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.719253 | 0.143 |
R-HSA-5683057 | MAPK family signaling cascades | 0.743395 | 0.129 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.745312 | 0.128 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.758343 | 0.120 |
R-HSA-68886 | M Phase | 0.775829 | 0.110 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.776670 | 0.110 |
R-HSA-162582 | Signal Transduction | 0.810765 | 0.091 |
R-HSA-72766 | Translation | 0.812174 | 0.090 |
R-HSA-6798695 | Neutrophil degranulation | 0.831002 | 0.080 |
R-HSA-9679506 | SARS-CoV Infections | 0.883409 | 0.054 |
R-HSA-382551 | Transport of small molecules | 0.888994 | 0.051 |
R-HSA-2262752 | Cellular responses to stress | 0.900932 | 0.045 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.906509 | 0.043 |
R-HSA-556833 | Metabolism of lipids | 0.923528 | 0.035 |
R-HSA-9824446 | Viral Infection Pathways | 0.929604 | 0.032 |
R-HSA-8953897 | Cellular responses to stimuli | 0.933525 | 0.030 |
R-HSA-212436 | Generic Transcription Pathway | 0.936239 | 0.029 |
R-HSA-1266738 | Developmental Biology | 0.940530 | 0.027 |
R-HSA-388396 | GPCR downstream signalling | 0.949570 | 0.022 |
R-HSA-372790 | Signaling by GPCR | 0.963409 | 0.016 |
R-HSA-1280218 | Adaptive Immune System | 0.982489 | 0.008 |
R-HSA-1643685 | Disease | 0.985978 | 0.006 |
R-HSA-5663205 | Infectious disease | 0.989432 | 0.005 |
R-HSA-168249 | Innate Immune System | 0.994293 | 0.002 |
R-HSA-597592 | Post-translational protein modification | 0.998498 | 0.001 |
R-HSA-392499 | Metabolism of proteins | 0.999261 | 0.000 |
R-HSA-168256 | Immune System | 0.999824 | 0.000 |
R-HSA-1430728 | Metabolism | 0.999973 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK2 |
0.782 | 0.454 | -3 | 0.873 |
SRPK1 |
0.782 | 0.463 | -3 | 0.896 |
CLK3 |
0.780 | 0.391 | 1 | 0.745 |
HIPK2 |
0.773 | 0.413 | 1 | 0.770 |
SRPK2 |
0.772 | 0.432 | -3 | 0.880 |
HIPK4 |
0.771 | 0.453 | 1 | 0.829 |
SRPK3 |
0.769 | 0.419 | -3 | 0.883 |
DYRK2 |
0.764 | 0.393 | 1 | 0.812 |
KIS |
0.764 | 0.309 | 1 | 0.730 |
CLK4 |
0.763 | 0.404 | -3 | 0.872 |
HIPK1 |
0.762 | 0.440 | 1 | 0.814 |
PIM3 |
0.761 | 0.359 | -3 | 0.853 |
RSK2 |
0.761 | 0.392 | -3 | 0.880 |
DYRK4 |
0.760 | 0.366 | 1 | 0.755 |
CLK1 |
0.758 | 0.402 | -3 | 0.854 |
DYRK3 |
0.755 | 0.420 | 1 | 0.831 |
PIM1 |
0.755 | 0.375 | -3 | 0.869 |
COT |
0.754 | 0.183 | 2 | 0.803 |
RSK4 |
0.753 | 0.379 | -3 | 0.863 |
CDKL1 |
0.753 | 0.402 | -3 | 0.887 |
MOS |
0.753 | 0.283 | 1 | 0.740 |
CDKL5 |
0.751 | 0.342 | -3 | 0.893 |
P90RSK |
0.749 | 0.367 | -3 | 0.886 |
CDK1 |
0.749 | 0.221 | 1 | 0.727 |
RSK3 |
0.748 | 0.354 | -3 | 0.880 |
DYRK1B |
0.747 | 0.348 | 1 | 0.753 |
PRKX |
0.746 | 0.307 | -3 | 0.814 |
CDC7 |
0.743 | 0.104 | 1 | 0.704 |
ICK |
0.743 | 0.343 | -3 | 0.869 |
CDK10 |
0.743 | 0.294 | 1 | 0.726 |
PKACB |
0.743 | 0.286 | -2 | 0.466 |
NDR2 |
0.743 | 0.211 | -3 | 0.808 |
GRK1 |
0.742 | 0.187 | -2 | 0.722 |
DYRK1A |
0.742 | 0.374 | 1 | 0.755 |
AURC |
0.741 | 0.195 | -2 | 0.468 |
MAPKAPK2 |
0.741 | 0.314 | -3 | 0.849 |
P70S6KB |
0.741 | 0.329 | -3 | 0.859 |
PIM2 |
0.741 | 0.387 | -3 | 0.867 |
NDR1 |
0.741 | 0.256 | -3 | 0.831 |
CAMK1B |
0.741 | 0.309 | -3 | 0.838 |
AKT2 |
0.740 | 0.366 | -3 | 0.862 |
BMPR1B |
0.740 | 0.161 | 1 | 0.673 |
HIPK3 |
0.740 | 0.385 | 1 | 0.762 |
NLK |
0.740 | 0.219 | 1 | 0.770 |
PRKD2 |
0.739 | 0.315 | -3 | 0.837 |
MSK1 |
0.738 | 0.301 | -3 | 0.880 |
NUAK2 |
0.738 | 0.256 | -3 | 0.838 |
CAMK2A |
0.736 | 0.243 | 2 | 0.755 |
MAK |
0.735 | 0.363 | -2 | 0.541 |
GRK7 |
0.735 | 0.169 | 1 | 0.608 |
PKACG |
0.734 | 0.227 | -2 | 0.514 |
MSK2 |
0.734 | 0.294 | -3 | 0.887 |
MTOR |
0.733 | 0.055 | 1 | 0.643 |
MOK |
0.733 | 0.420 | 1 | 0.829 |
PASK |
0.733 | 0.347 | -3 | 0.831 |
SKMLCK |
0.733 | 0.217 | -2 | 0.621 |
PKN2 |
0.732 | 0.224 | -3 | 0.815 |
CDK3 |
0.732 | 0.181 | 1 | 0.691 |
MAPKAPK3 |
0.732 | 0.289 | -3 | 0.839 |
PKN3 |
0.731 | 0.221 | -3 | 0.832 |
CAMLCK |
0.731 | 0.239 | -2 | 0.616 |
ATR |
0.731 | 0.069 | 1 | 0.671 |
GCN2 |
0.730 | -0.001 | 2 | 0.750 |
DSTYK |
0.730 | 0.031 | 2 | 0.836 |
IKKB |
0.729 | 0.009 | -2 | 0.547 |
CAMK1G |
0.729 | 0.320 | -3 | 0.850 |
CDK7 |
0.729 | 0.180 | 1 | 0.741 |
CDK19 |
0.729 | 0.164 | 1 | 0.712 |
P38G |
0.729 | 0.194 | 1 | 0.668 |
TGFBR2 |
0.729 | 0.073 | -2 | 0.683 |
CDK8 |
0.728 | 0.146 | 1 | 0.729 |
PRKD3 |
0.728 | 0.312 | -3 | 0.855 |
CDK18 |
0.728 | 0.189 | 1 | 0.706 |
GRK5 |
0.728 | 0.041 | -3 | 0.691 |
DAPK2 |
0.727 | 0.243 | -3 | 0.825 |
PAK1 |
0.727 | 0.184 | -2 | 0.568 |
NIK |
0.727 | 0.243 | -3 | 0.788 |
JNK3 |
0.727 | 0.194 | 1 | 0.717 |
MYLK4 |
0.726 | 0.244 | -2 | 0.556 |
JNK2 |
0.726 | 0.207 | 1 | 0.696 |
LATS2 |
0.726 | 0.147 | -5 | 0.617 |
RAF1 |
0.725 | 0.028 | 1 | 0.621 |
PRPK |
0.725 | -0.054 | -1 | 0.675 |
PKCD |
0.725 | 0.187 | 2 | 0.729 |
CDK5 |
0.725 | 0.160 | 1 | 0.751 |
MLK3 |
0.725 | 0.084 | 2 | 0.720 |
PKCB |
0.725 | 0.199 | 2 | 0.700 |
MLK1 |
0.725 | 0.026 | 2 | 0.772 |
PKACA |
0.725 | 0.260 | -2 | 0.423 |
PRKD1 |
0.725 | 0.201 | -3 | 0.837 |
GSK3A |
0.725 | 0.157 | 4 | 0.516 |
CDK13 |
0.724 | 0.157 | 1 | 0.723 |
AURB |
0.724 | 0.154 | -2 | 0.468 |
AKT3 |
0.724 | 0.358 | -3 | 0.853 |
GRK6 |
0.724 | 0.049 | 1 | 0.658 |
BMPR2 |
0.724 | -0.025 | -2 | 0.678 |
CDK12 |
0.724 | 0.181 | 1 | 0.702 |
CAMK2B |
0.723 | 0.162 | 2 | 0.713 |
WNK1 |
0.723 | 0.140 | -2 | 0.605 |
CDK14 |
0.723 | 0.227 | 1 | 0.726 |
PKCG |
0.723 | 0.184 | 2 | 0.717 |
AURA |
0.722 | 0.118 | -2 | 0.475 |
ERK1 |
0.722 | 0.175 | 1 | 0.684 |
DLK |
0.722 | 0.103 | 1 | 0.632 |
CHAK2 |
0.722 | 0.034 | -1 | 0.705 |
CAMK2G |
0.722 | -0.011 | 2 | 0.739 |
CDK2 |
0.722 | 0.126 | 1 | 0.751 |
ERK5 |
0.721 | 0.046 | 1 | 0.697 |
P70S6K |
0.721 | 0.330 | -3 | 0.861 |
RIPK3 |
0.721 | 0.041 | 3 | 0.532 |
PKG2 |
0.721 | 0.185 | -2 | 0.456 |
GRK4 |
0.721 | 0.048 | -2 | 0.714 |
CDK17 |
0.721 | 0.173 | 1 | 0.672 |
CDK9 |
0.720 | 0.168 | 1 | 0.722 |
LATS1 |
0.720 | 0.173 | -3 | 0.803 |
HUNK |
0.720 | 0.034 | 2 | 0.785 |
P38B |
0.719 | 0.175 | 1 | 0.684 |
PKCA |
0.719 | 0.165 | 2 | 0.689 |
SGK1 |
0.719 | 0.360 | -3 | 0.850 |
SGK3 |
0.719 | 0.281 | -3 | 0.853 |
NEK6 |
0.719 | -0.025 | -2 | 0.641 |
AKT1 |
0.718 | 0.301 | -3 | 0.853 |
MLK4 |
0.718 | 0.053 | 2 | 0.695 |
ACVR2B |
0.718 | 0.059 | -2 | 0.674 |
IRE1 |
0.718 | 0.090 | 1 | 0.675 |
P38A |
0.717 | 0.167 | 1 | 0.726 |
PRP4 |
0.717 | 0.132 | -3 | 0.637 |
PAK3 |
0.717 | 0.141 | -2 | 0.556 |
ALK4 |
0.717 | 0.063 | -2 | 0.687 |
CAMK2D |
0.717 | 0.122 | -3 | 0.806 |
BMPR1A |
0.717 | 0.084 | 1 | 0.657 |
AMPKA1 |
0.717 | 0.155 | -3 | 0.816 |
GRK2 |
0.717 | 0.052 | -2 | 0.609 |
ACVR2A |
0.716 | 0.042 | -2 | 0.669 |
P38D |
0.716 | 0.176 | 1 | 0.687 |
AMPKA2 |
0.716 | 0.185 | -3 | 0.826 |
ERK2 |
0.716 | 0.160 | 1 | 0.709 |
MNK1 |
0.716 | 0.140 | -2 | 0.554 |
MST4 |
0.715 | 0.052 | 2 | 0.785 |
MAPKAPK5 |
0.715 | 0.251 | -3 | 0.866 |
PKCZ |
0.715 | 0.149 | 2 | 0.724 |
ALK2 |
0.715 | 0.071 | -2 | 0.696 |
PKCE |
0.715 | 0.239 | 2 | 0.700 |
PKCH |
0.715 | 0.169 | 2 | 0.680 |
PHKG1 |
0.715 | 0.158 | -3 | 0.818 |
DRAK1 |
0.715 | 0.096 | 1 | 0.607 |
PDHK4 |
0.715 | -0.186 | 1 | 0.661 |
JNK1 |
0.715 | 0.176 | 1 | 0.700 |
GSK3B |
0.714 | 0.115 | 4 | 0.518 |
TGFBR1 |
0.714 | 0.047 | -2 | 0.678 |
CK1E |
0.714 | 0.075 | -3 | 0.447 |
PAK2 |
0.714 | 0.136 | -2 | 0.561 |
CAMK4 |
0.714 | 0.142 | -3 | 0.802 |
DCAMKL1 |
0.714 | 0.245 | -3 | 0.826 |
CDK16 |
0.714 | 0.166 | 1 | 0.685 |
ATM |
0.713 | 0.006 | 1 | 0.623 |
TTBK2 |
0.713 | 0.026 | 2 | 0.680 |
ANKRD3 |
0.713 | 0.022 | 1 | 0.656 |
NEK7 |
0.713 | -0.096 | -3 | 0.683 |
RIPK1 |
0.712 | 0.099 | 1 | 0.663 |
IKKE |
0.712 | -0.115 | 1 | 0.486 |
BRSK1 |
0.712 | 0.162 | -3 | 0.838 |
TBK1 |
0.712 | -0.122 | 1 | 0.492 |
DAPK1 |
0.711 | 0.270 | -3 | 0.858 |
CK1D |
0.711 | 0.089 | -3 | 0.399 |
CAMK1D |
0.711 | 0.297 | -3 | 0.829 |
PLK1 |
0.711 | -0.007 | -2 | 0.637 |
PAK6 |
0.711 | 0.134 | -2 | 0.493 |
GRK3 |
0.711 | 0.056 | -2 | 0.608 |
CHK2 |
0.711 | 0.335 | -3 | 0.835 |
DAPK3 |
0.710 | 0.261 | -3 | 0.847 |
PKR |
0.710 | 0.122 | 1 | 0.693 |
MLK2 |
0.710 | -0.015 | 2 | 0.763 |
ULK2 |
0.710 | -0.141 | 2 | 0.705 |
SBK |
0.709 | 0.361 | -3 | 0.817 |
PINK1 |
0.709 | 0.039 | 1 | 0.765 |
NUAK1 |
0.709 | 0.159 | -3 | 0.834 |
MASTL |
0.709 | -0.074 | -2 | 0.598 |
MARK4 |
0.709 | -0.002 | 4 | 0.706 |
SMMLCK |
0.709 | 0.240 | -3 | 0.850 |
IKKA |
0.708 | -0.073 | -2 | 0.551 |
TSSK2 |
0.708 | 0.056 | -5 | 0.635 |
MELK |
0.708 | 0.186 | -3 | 0.824 |
IRE2 |
0.708 | 0.040 | 2 | 0.650 |
TLK2 |
0.707 | 0.019 | 1 | 0.617 |
SIK |
0.707 | 0.170 | -3 | 0.822 |
MNK2 |
0.706 | 0.085 | -2 | 0.537 |
CDK4 |
0.706 | 0.192 | 1 | 0.700 |
QSK |
0.706 | 0.110 | 4 | 0.689 |
TSSK1 |
0.706 | 0.091 | -3 | 0.812 |
CDK6 |
0.706 | 0.168 | 1 | 0.712 |
CK1A2 |
0.706 | 0.064 | -3 | 0.410 |
TLK1 |
0.705 | 0.067 | -2 | 0.685 |
CRIK |
0.705 | 0.375 | -3 | 0.860 |
MRCKB |
0.705 | 0.286 | -3 | 0.840 |
CK2A2 |
0.704 | 0.031 | 1 | 0.622 |
YSK4 |
0.704 | -0.035 | 1 | 0.548 |
PDHK1 |
0.704 | -0.238 | 1 | 0.624 |
PLK3 |
0.703 | -0.039 | 2 | 0.726 |
MEK1 |
0.703 | -0.038 | 2 | 0.797 |
PERK |
0.703 | 0.054 | -2 | 0.681 |
ROCK2 |
0.703 | 0.296 | -3 | 0.841 |
DMPK1 |
0.703 | 0.312 | -3 | 0.837 |
WNK3 |
0.703 | -0.087 | 1 | 0.609 |
PKCT |
0.703 | 0.173 | 2 | 0.674 |
BUB1 |
0.702 | 0.217 | -5 | 0.632 |
GAK |
0.702 | 0.166 | 1 | 0.713 |
PKCI |
0.702 | 0.160 | 2 | 0.702 |
ULK1 |
0.702 | -0.144 | -3 | 0.646 |
PAK4 |
0.702 | 0.142 | -2 | 0.481 |
MEKK3 |
0.702 | 0.048 | 1 | 0.597 |
FAM20C |
0.702 | -0.025 | 2 | 0.526 |
MRCKA |
0.702 | 0.261 | -3 | 0.838 |
MST3 |
0.702 | 0.101 | 2 | 0.811 |
CHAK1 |
0.702 | -0.020 | 2 | 0.723 |
QIK |
0.701 | 0.061 | -3 | 0.787 |
DCAMKL2 |
0.701 | 0.161 | -3 | 0.823 |
SMG1 |
0.701 | -0.034 | 1 | 0.635 |
VRK2 |
0.701 | -0.037 | 1 | 0.729 |
NEK9 |
0.701 | -0.121 | 2 | 0.763 |
SNRK |
0.701 | 0.064 | 2 | 0.612 |
CAMK1A |
0.700 | 0.297 | -3 | 0.828 |
ERK7 |
0.700 | 0.088 | 2 | 0.561 |
MPSK1 |
0.700 | 0.130 | 1 | 0.703 |
CK2A1 |
0.700 | 0.038 | 1 | 0.604 |
PAK5 |
0.699 | 0.129 | -2 | 0.468 |
BRSK2 |
0.699 | 0.075 | -3 | 0.807 |
MARK3 |
0.699 | 0.046 | 4 | 0.653 |
NIM1 |
0.698 | 0.000 | 3 | 0.557 |
MEK5 |
0.698 | 0.011 | 2 | 0.764 |
DNAPK |
0.697 | -0.007 | 1 | 0.531 |
PKN1 |
0.696 | 0.231 | -3 | 0.852 |
HASPIN |
0.695 | 0.212 | -1 | 0.710 |
BCKDK |
0.695 | -0.169 | -1 | 0.575 |
CK1G1 |
0.694 | 0.004 | -3 | 0.442 |
NEK8 |
0.694 | 0.055 | 2 | 0.753 |
CHK1 |
0.694 | 0.055 | -3 | 0.783 |
TAO3 |
0.694 | 0.028 | 1 | 0.587 |
MEKK2 |
0.693 | -0.005 | 2 | 0.740 |
STK33 |
0.693 | 0.064 | 2 | 0.615 |
ROCK1 |
0.693 | 0.287 | -3 | 0.841 |
HRI |
0.693 | -0.060 | -2 | 0.663 |
WNK4 |
0.691 | 0.061 | -2 | 0.594 |
GCK |
0.691 | 0.088 | 1 | 0.576 |
SSTK |
0.690 | 0.064 | 4 | 0.674 |
ZAK |
0.689 | -0.071 | 1 | 0.572 |
PLK2 |
0.689 | -0.001 | -3 | 0.639 |
NEK2 |
0.689 | -0.082 | 2 | 0.753 |
PDK1 |
0.689 | 0.116 | 1 | 0.597 |
NEK5 |
0.688 | -0.028 | 1 | 0.633 |
MARK1 |
0.688 | 0.020 | 4 | 0.658 |
PHKG2 |
0.688 | 0.088 | -3 | 0.799 |
BRAF |
0.687 | -0.038 | -4 | 0.734 |
MARK2 |
0.687 | -0.010 | 4 | 0.618 |
SLK |
0.687 | 0.055 | -2 | 0.511 |
IRAK4 |
0.686 | 0.015 | 1 | 0.643 |
TAK1 |
0.686 | 0.079 | 1 | 0.597 |
LKB1 |
0.686 | 0.049 | -3 | 0.677 |
HPK1 |
0.686 | 0.085 | 1 | 0.558 |
LRRK2 |
0.685 | 0.108 | 2 | 0.778 |
YANK3 |
0.685 | 0.048 | 2 | 0.424 |
CK1A |
0.685 | 0.060 | -3 | 0.325 |
MEKK1 |
0.685 | -0.114 | 1 | 0.604 |
CAMKK1 |
0.683 | -0.066 | -2 | 0.537 |
EEF2K |
0.682 | -0.007 | 3 | 0.660 |
NEK11 |
0.682 | -0.039 | 1 | 0.573 |
PKG1 |
0.682 | 0.169 | -2 | 0.389 |
CAMKK2 |
0.682 | -0.016 | -2 | 0.522 |
LOK |
0.682 | 0.074 | -2 | 0.527 |
TNIK |
0.681 | 0.043 | 3 | 0.703 |
PBK |
0.680 | 0.107 | 1 | 0.636 |
TAO2 |
0.680 | -0.027 | 2 | 0.769 |
KHS2 |
0.680 | 0.083 | 1 | 0.561 |
TTBK1 |
0.680 | -0.073 | 2 | 0.604 |
OSR1 |
0.679 | 0.050 | 2 | 0.752 |
MST2 |
0.678 | -0.071 | 1 | 0.575 |
PLK4 |
0.678 | -0.110 | 2 | 0.575 |
MEKK6 |
0.675 | -0.018 | 1 | 0.577 |
HGK |
0.675 | -0.028 | 3 | 0.692 |
KHS1 |
0.674 | 0.034 | 1 | 0.544 |
TTK |
0.674 | 0.041 | -2 | 0.681 |
MAP2K6_TYR |
0.674 | 0.169 | -1 | 0.689 |
PDHK4_TYR |
0.673 | 0.152 | 2 | 0.811 |
MST1 |
0.673 | -0.042 | 1 | 0.550 |
PDHK3_TYR |
0.672 | 0.136 | 4 | 0.747 |
BMPR2_TYR |
0.672 | 0.136 | -1 | 0.709 |
MINK |
0.672 | -0.048 | 1 | 0.551 |
VRK1 |
0.671 | -0.049 | 2 | 0.743 |
MAP2K4_TYR |
0.670 | 0.154 | -1 | 0.677 |
NEK4 |
0.670 | -0.074 | 1 | 0.573 |
MAP3K15 |
0.670 | -0.067 | 1 | 0.553 |
CK1G2 |
0.670 | 0.091 | -3 | 0.363 |
IRAK1 |
0.668 | -0.158 | -1 | 0.617 |
TESK1_TYR |
0.668 | 0.125 | 3 | 0.688 |
ALPHAK3 |
0.668 | 0.036 | -1 | 0.609 |
PDHK1_TYR |
0.667 | 0.086 | -1 | 0.714 |
NEK1 |
0.667 | -0.061 | 1 | 0.602 |
PINK1_TYR |
0.665 | 0.094 | 1 | 0.673 |
LIMK2_TYR |
0.665 | 0.163 | -3 | 0.746 |
PKMYT1_TYR |
0.662 | 0.045 | 3 | 0.650 |
MYO3B |
0.662 | 0.035 | 2 | 0.757 |
BIKE |
0.662 | 0.036 | 1 | 0.646 |
YSK1 |
0.662 | -0.043 | 2 | 0.744 |
TXK |
0.661 | 0.066 | 1 | 0.665 |
EPHA6 |
0.661 | 0.054 | -1 | 0.711 |
CK1G3 |
0.661 | 0.040 | -3 | 0.284 |
MAP2K7_TYR |
0.660 | -0.028 | 2 | 0.786 |
MEK2 |
0.660 | -0.178 | 2 | 0.739 |
EPHB4 |
0.656 | -0.002 | -1 | 0.671 |
FGR |
0.656 | 0.013 | 1 | 0.643 |
RIPK2 |
0.655 | -0.170 | 1 | 0.515 |
MYO3A |
0.654 | -0.028 | 1 | 0.603 |
YANK2 |
0.654 | 0.009 | 2 | 0.439 |
LIMK1_TYR |
0.653 | -0.010 | 2 | 0.760 |
BLK |
0.653 | 0.025 | -1 | 0.700 |
FLT1 |
0.653 | 0.043 | -1 | 0.689 |
EPHA4 |
0.652 | 0.014 | 2 | 0.746 |
FYN |
0.652 | 0.044 | -1 | 0.697 |
LCK |
0.651 | 0.012 | -1 | 0.704 |
PTK2 |
0.651 | 0.089 | -1 | 0.679 |
YES1 |
0.650 | -0.046 | -1 | 0.675 |
SYK |
0.650 | 0.109 | -1 | 0.667 |
ITK |
0.649 | -0.019 | -1 | 0.647 |
RET |
0.649 | -0.057 | 1 | 0.600 |
ABL2 |
0.649 | 0.007 | -1 | 0.625 |
ASK1 |
0.649 | -0.104 | 1 | 0.547 |
AAK1 |
0.648 | 0.054 | 1 | 0.576 |
WEE1_TYR |
0.647 | 0.045 | -1 | 0.588 |
MET |
0.647 | 0.013 | 3 | 0.567 |
MST1R |
0.646 | -0.085 | 3 | 0.588 |
TNK2 |
0.646 | 0.013 | 3 | 0.517 |
KDR |
0.646 | -0.008 | 3 | 0.536 |
NEK3 |
0.646 | -0.124 | 1 | 0.548 |
TAO1 |
0.645 | -0.071 | 1 | 0.506 |
DDR1 |
0.645 | -0.082 | 4 | 0.687 |
SRMS |
0.645 | -0.047 | 1 | 0.646 |
ABL1 |
0.643 | -0.027 | -1 | 0.613 |
JAK3 |
0.642 | -0.086 | 1 | 0.588 |
FER |
0.642 | -0.127 | 1 | 0.666 |
EPHB2 |
0.642 | -0.057 | -1 | 0.664 |
HCK |
0.642 | -0.098 | -1 | 0.685 |
TYRO3 |
0.641 | -0.142 | 3 | 0.575 |
BMX |
0.641 | -0.038 | -1 | 0.579 |
STLK3 |
0.641 | -0.122 | 1 | 0.527 |
KIT |
0.641 | -0.081 | 3 | 0.585 |
CSF1R |
0.641 | -0.121 | 3 | 0.573 |
FGFR2 |
0.641 | -0.069 | 3 | 0.575 |
EPHB1 |
0.641 | -0.096 | 1 | 0.626 |
EPHB3 |
0.640 | -0.074 | -1 | 0.660 |
INSRR |
0.638 | -0.104 | 3 | 0.512 |
EPHA7 |
0.638 | -0.049 | 2 | 0.735 |
TEC |
0.637 | -0.073 | -1 | 0.570 |
EPHA3 |
0.636 | -0.060 | 2 | 0.707 |
SRC |
0.636 | -0.032 | -1 | 0.666 |
PTK2B |
0.636 | -0.012 | -1 | 0.606 |
ROS1 |
0.635 | -0.185 | 3 | 0.530 |
FGFR3 |
0.635 | -0.063 | 3 | 0.547 |
FLT3 |
0.634 | -0.113 | 3 | 0.579 |
EPHA8 |
0.634 | -0.035 | -1 | 0.665 |
ERBB2 |
0.634 | -0.079 | 1 | 0.559 |
EPHA5 |
0.634 | -0.040 | 2 | 0.721 |
TEK |
0.634 | -0.099 | 3 | 0.512 |
NEK10_TYR |
0.633 | -0.081 | 1 | 0.484 |
ZAP70 |
0.633 | 0.083 | -1 | 0.571 |
FRK |
0.633 | -0.083 | -1 | 0.696 |
LYN |
0.633 | -0.084 | 3 | 0.508 |
TNK1 |
0.633 | -0.018 | 3 | 0.563 |
TNNI3K_TYR |
0.632 | -0.059 | 1 | 0.620 |
TYK2 |
0.632 | -0.280 | 1 | 0.582 |
JAK2 |
0.632 | -0.226 | 1 | 0.576 |
MERTK |
0.631 | -0.110 | 3 | 0.556 |
DDR2 |
0.631 | -0.014 | 3 | 0.495 |
MATK |
0.630 | -0.057 | -1 | 0.565 |
PDGFRB |
0.630 | -0.166 | 3 | 0.575 |
FLT4 |
0.630 | -0.103 | 3 | 0.542 |
PTK6 |
0.629 | -0.140 | -1 | 0.572 |
BTK |
0.629 | -0.175 | -1 | 0.603 |
EPHA1 |
0.628 | -0.102 | 3 | 0.540 |
ERBB4 |
0.626 | -0.014 | 1 | 0.524 |
FGFR1 |
0.626 | -0.160 | 3 | 0.519 |
AXL |
0.626 | -0.147 | 3 | 0.545 |
EPHA2 |
0.625 | -0.041 | -1 | 0.638 |
EGFR |
0.625 | -0.070 | 1 | 0.487 |
FGFR4 |
0.622 | -0.076 | -1 | 0.607 |
LTK |
0.622 | -0.152 | 3 | 0.502 |
PDGFRA |
0.621 | -0.211 | 3 | 0.576 |
CSK |
0.621 | -0.115 | 2 | 0.734 |
ALK |
0.621 | -0.175 | 3 | 0.468 |
NTRK1 |
0.619 | -0.210 | -1 | 0.619 |
JAK1 |
0.619 | -0.184 | 1 | 0.518 |
NTRK3 |
0.617 | -0.151 | -1 | 0.582 |
NTRK2 |
0.615 | -0.234 | 3 | 0.536 |
INSR |
0.613 | -0.208 | 3 | 0.495 |
IGF1R |
0.608 | -0.149 | 3 | 0.452 |
MUSK |
0.606 | -0.145 | 1 | 0.476 |
FES |
0.592 | -0.171 | -1 | 0.549 |